Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

Add Yahoo as a preferred source to see more of our stories on Google. Medtronic said Monday it received 510(k) clearance from the Food and Drug Administration for an app to connect its smart insulin ...

Medtronic (NYSE:MDT) has launched its MiniMed Go Smart MDI system with the Simplera sensor in Europe. The system connects the InPen smart insulin pen and a continuous glucose sensor into a single ...

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

DUBLIN, -- Medtronic plc, the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company's first app-based research study. Using data collected from the ...

Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

Medical technology provider Medtronic and Fitbit joined forces to create a mobile app to help patients with diabetes better track their blood glucose levels and sync data from their wearable devices ...

At Samsung Developer Conference 2019 today, Medtronic and Samsung showed off a Galaxy smartphone app, Patient Programmer, that allows patients to manage their own therapy for Parkinson’s disease.

With the COVID-19 pandemic still making it difficult to initiate studies in research centers, virtual clinical studies have become all the rage—and Medtronic is hopping on the bandwagon. The medtech ...